Search Results - "Mizui, Masaaki"

Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale by Tanaka, Junko, Koyama, Tomiko, Mizui, Masaaki, Uchida, Shigeru, Katayama, Keiko, Matsuo, Junko, Akita, Tomoyuki, Nakashima, Ayumu, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…To estimate total numbers of undiagnosed carriers of hepatitis C virus (HCV) and hepatitis B virus (HBV) in Japan. Area- and age-specific prevalence of HCV as…”
Get more information

Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C by Komiya, Yutaka, Katayama, Keiko, Yugi, Hisao, Mizui, Masaaki, Matsukura, Harumichi, Tomoguri, Tetsushi, Miyakawa, Yuzo, Tabuchi, Ayako, Tanaka, Junko, Yoshizawa, Hiroshi

“…BACKGROUND: In planning optimal hepatitis B virus (HBV) blood screening strategies, the minimum infectious dose and early dynamics of HBV need to be determined…”
Get full text

Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000 by Tanaka, Junko, Kumagai, Junko, Katayama, Keiko, Komiya, Yutaka, Mizui, Masaaki, Yamanaka, Retsuji, Suzuki, Kou, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…Carriers of hepatitis B virus (HBV) and hepatitis C virus (HCV) in Japan were estimated on a national basis. Sera from the first-time blood donors aged 16-64…”
Get more information

Follow up of the 987 blood donors found with hepatitis C virus infection over 9-18 years by Matsuo, Junko, Mizui, Masaaki, Okita, Hajime, Katayama, Keiko, Aimitsu, Shiomi, Sakata, Tatsuro, Obayashi, Makoto, Nakanishi, Toshio, Chayama, Kazuaki, Miyakawa, Yuzo, Yoshizawa, Hiroshi, Tanaka, Junko

“…Aim:  To follow up blood donors found with hepatitis C virus (HCV) infection, to improve the outcome by antiviral treatments. Methods:  Between 1991 and 2001,…”
Get full text

Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing — Japanese experience by Yugi, Hisao, Mizui, Masaaki, Tanaka, Junko, Yoshizawa, Hiroshi

Get full text

Incidence rates of hepatitis B and C virus infections among blood donors in Hiroshima, Japan, during 10 years from 1994 to 2004 by Tanaka, Junko, Mizui, Masaaki, Nagakami, Hideki, Katayama, Keiko, Tabuchi, Ayako, Komiya, Yutaka, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…Although prevalence rates of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections have kept decreasing in blood donors, there is little information…”
Get more information

Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years by Mizui, Masaaki, Tanaka, Junko, Katayama, Keiko, Nakanishi, Toshio, Obayashi, Makoto, Aimitsu, Shiomi, Yoshida, Tomoo, Inoue, Junichi, Yokoyama, Tatsuji, Tsuji, Keiji, Arataki, Keiko, Yamaguchi, Syuji, Miura, Toshio, Kitamoto, Mikiya, Takezaki, Eiichi, Orimen, Shigeo, Sakata, Tatsurou, Kamada, Kouji, Maruhashi, Akira, Tamura, Tooru, Nakamura, Toshio, Ishida, Kunio, Teramen, Kazushi, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…Aim:  To portray liver disease and project outcomes in carriers of hepatitis C virus (HCV) in the general population. Methods:  Liver disease was evaluated in…”
Get full text

Natural histories of hepatitis C virus infection in men and women simulated by the Markov model by Tanaka, Junko, Kumada, Hiromitsu, Ikeda, Kenji, Chayama, Kazuaki, Mizui, Masaaki, Hino, Kunihiko, Katayama, Keiko, Kumagai, Junko, Komiya, Yutaka, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…The Markov model was introduced to simulate natural histories of hepatitis C virus (HCV) infection in men and women. The data set was constructed on 942 HCV…”
Get full text

Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission by Katayama, Keiko, Kumagai, Junko, Komiya, Yutaka, Mizui, Masaaki, Yugi, Hisao, Kishimoto, Shinya, Yamanaka, Retsuji, Tamatsukuri, Shigeru, Tomoguri, Tetsushi, Miyakawa, Yuzo, Tanaka, Junko, Yoshizawa, Hiroshi

“…To determine the copy number of hepatitis C virus (HCV) RNA, determined by nucleic acid amplification test (NAT) for screening blood units in Japan, that can…”
Get more information

Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: Transmission experiments to chimeric mice with human liver repopulated hepatocytes by Tabuchi, Ayako, Tanaka, Junko, Katayama, Keiko, Mizui, Masaaki, Matsukura, Harumichi, Yugi, Hisao, Shimada, Takashi, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…Studies of hepatitis B virus (HBV) infection in non-human primates such as chimpanzees are no longer possible due to ethical considerations and the endangered…”
Get full text

Interferon alone or combined with ribavirin for acute prolonged infection with hepatitis C virus in chimpanzees by Tomoguri, Tetsushi, Katayama, Keiko, Tanaka, Junko, Yugi, Hisao, Mizui, Masaaki, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…Infection with hepatitis C virus (HCV) persisted for longer than 29 weeks in 2 chimpanzees after they had been inoculated with it experimentally. One of them…”
Get more information

Minimum infectious dose of hepatitisB virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotypeC by Komiya, Yutaka, Katayama, Keiko, Yugi, Hisao, Mizui, Masaaki, Matsukura, Harumichi, Tomoguri, Tetsushi, Miyakawa, Yuzo, Tabuchi, Ayako, Tanaka, Junko, Yoshizawa, Hiroshi

“…BACKGROUND: In planning optimal hepatitisB virus (HBV) blood screening strategies, the minimum infectious dose and early dynamics of HBV need to be determined…”
Get full text

Hepatitis B Virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience: Hepatitis B: a review of the role of NAT in enhancing blood safety by YUGI, Hisao, MIZUI, Masaaki, TANAKA, Junko, YOSHIZAWA, Hiroshi

Get full text

Early dynamics of hepatitis C virus in the circulation of chimpanzees with experimental infection by Tanaka, Junko, Katayama, Keiko, Kumagai, Junko, Komiya, Yutaka, Yugi, Hisao, Kishimoto, Shinya, Mizui, Masaaki, Tomoguri, Tetsushi, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…Two chimpanzees were inoculated with hepatitis C virus (HCV) and followed on a daily basis for 12 days. HCV RNA became detectable in their sera on day 5 by…”
Get more information

Lack of epidemiological evidence for a role of resolved hepatitis B virus infection in hepatocarcinogenesis in patients infected with hepatitis C virus in Japan by Hiraoka, Tetsuro, Katayama, Keiko, Tanaka, Junko, Ohno, Naofumi, Joko, Kouji, Komiya, Yutaka, Kumagai, Junko, Mizui, Masaaki, Hino, Kunihiko, Miyakawa, Yuzo, Yoshizawa, Hiroshi

“…The role of resolved hepatitis B virus (HBV) infection in promoting hepatocellular carcinoma (HCC) in patients infected with hepatitis C virus (HCV) in Japan…”
Get more information

Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody by Gotoh, K, Mima, S, Uchida, T, Shikata, T, Yoshizawa, K, Irie, M, Mizui, M

“…The nucleotide sequences of the precore/core and X open reading frames (ORFs) of hepatitis B virus (HBV) were studied in four subjects who were serologically…”
Get more information